Regeneron, Sanofi halt trial for experimental coronavirus drug, shares fall

·

·

Regeneron, Sanofi halt trial for experimental coronavirus drug, shares fall

Shares of Regeneron Pharmaceuticals Inc. REGN, +2.18% were down 2.4% and Sanofi’s SNY, +0.68% stock declined 1.7% in after-hours trading on Friday after the companies halted a Phase 3 clinical trial testing their rheumatoid arthritis drug Kevzara as a …
See Original Article

CBO Sees Double-Digit Jobless Rate Through 2020, GDP to Shrink 5.9%

WASHINGTON—Unemployment is likely to remain in double digits through year’s end, and the economic downturn will be more severe than previously forecast, according to projections released Thursday by the Congressional Budget Office. The CBO …
See Original Article

Here's Why Berkshire Hathaway Shares Lost 21% in the First Half of 2020

On paper, it would appear the first half of 2020 set up nicely for Warren Buffett, the investor who famously said, “Be greedy when others are fearful, and fearful when others were greedy.” Investors were certainly fearful in February and March as the COVID-19 …
See Original Article

FDA Approves New HIV Treatment for Patients With Limited Treatment Options

PR Newswire. SILVER SPRING, Md., July 2, 2020. SILVER SPRING, Md., July 2, 2020 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have …
See Original Article

Amazon CEO Jeff Bezos's Net Worth Tops Pre-Divorce Height: Bloomberg Index

Bezos's previous record was a net worth of $167.7 billion — reached in September, 2018, according to Bloomberg. The 56-year old's wife MacKenzie
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.